ArticleFrontiers in veterinary science2026
Cross-border introduction risk of Rift Valley fever virus: surveillance evidence from intercepted livestock in southwestern Saudi Arabia.
Article in Frontiers in veterinary science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Rift Valley fever (RVF) is a mosquito-borne transboundary zoonotic disease with major implications for animal and public health. Following the 2000 outbreak in Saudi Arabia and Yemen, the risk of reintroduction through cross-border livestock movement remains a continuing concern. This study aimed to estimate the seroprevalence of Rift Valley fever virus (RVFV) among illegally introduced livestock intercepted in the Jazan region of southwestern Saudi Arabia and to assess the added value of combined serological and molecular testing for detecting recent infection under routine surveillance conditions. Methods: Cross-sectional study was conducted using routine diagnostic data from confiscated livestock intercepted between January 2017 and December 2019. Results and discussion: A total of 2,202 serum samples from sheep, cattle, and camels were screened using a commercial competitive ELISA kit (ID.vet, France). Seroreactive samples were further characterized using IgM ELISA and real-time polymerase chain reaction (RT-PCR). Seroprevalence estimates were calculated with 95% confidence intervals (CI) and by species and year of collection. Agreement between IgM ELISA and RT-PCR was evaluated using Cohen's kappa coefficient. Overall, 38 of 2,202 samples were cELISA-positive, giving an RVFV seroprevalence of 1.7% (95% CI: 1.3-2.4). Of the Seroreactive samples, 6/38 (15.8%; 95% CI: 7.4-30.4) were IgM-positive, indicating recent infection. Three samples were RT-PCR-confirmed, and all molecularly confirmed cases were also IgM-positive. Agreement between IgM and PCR was moderate (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.